ICD-10 Code A81.2 | Progressive multifocal leukoencephalopathy Symptoms, Diagnosis, Billing

Progressive multifocal leukoencephalopathy (PML) is a rare and often fatal demyelinating disease of the central nervous system caused by the reactivation of the JC virus, primarily affecting immunocompromised individuals. The ICD-10 Code A81.2 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage this serious condition.

What is ICD-10 Code A81.2 for Progressive multifocal leukoencephalopathy?

ICD-10 Code A81.2 represents Progressive multifocal leukoencephalopathy, a severe neurological disorder characterized by the destruction of myelin in the brain due to JC virus reactivation. This code should be used in clinical documentation and billing when diagnosing patients with PML, particularly in the context of underlying immunosuppression or complications related to HIV/AIDS, cancer, or immunosuppressive therapies.

ICD-10 Code A81.2 – Clinical Definition and Explanation of Progressive multifocal leukoencephalopathy

Progressive multifocal leukoencephalopathy is caused by the JC virus, which typically remains dormant in healthy individuals but can reactivate in those with weakened immune systems. The disease progresses rapidly, leading to severe neurological deficits and necessitating urgent medical attention.

Key Clinical Features:

• Rapidly progressive neurological symptoms, including weakness, vision problems, and cognitive decline.
• Demyelination observed on MRI scans, often with characteristic lesions.
• Association with immunocompromised states, such as HIV/AIDS or organ transplantation.
• Potential for severe disability or death if not promptly recognized and managed.

ICD-10 Code A81.2 for Progressive multifocal leukoencephalopathy – SOAP Notes & Clinical Use

ICD-10 Code A81.2 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of patients with Progressive multifocal leukoencephalopathy. It plays a crucial role in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code A81.2 for Progressive multifocal leukoencephalopathy Mean in SOAP Notes?

In SOAP notes, ICD-10 Code A81.2 connects subjective patient reports and objective clinical findings to a formal diagnosis of Progressive multifocal leukoencephalopathy. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code A81.2 – Progressive multifocal leukoencephalopathy

The management of Progressive multifocal leukoencephalopathy requires immediate medical intervention, often necessitating hospitalization due to the severity of the condition.

Antibiotic Therapy:

• Not applicable as PML is not caused by a bacterial infection.

Supportive Care:

• Symptomatic treatment for neurological deficits.
• Physical therapy to maintain mobility and function.
• Psychological support for cognitive and emotional challenges.

Infection Control:

• Standard precautions to prevent transmission of JC virus in immunocompromised settings.

How to Document Symptoms of Progressive multifocal leukoencephalopathy (ICD-10 A81.2) in SOAP Notes

Subjective:

• Patient reports progressive weakness and difficulty with coordination.
• Complaints of vision changes, including blurred vision.
• History of immunosuppression due to HIV/AIDS or recent chemotherapy.
• Cognitive decline noted by family members.

Objective:

• Neurological examination reveals ataxia and visual field deficits.
• MRI shows multifocal white matter lesions consistent with demyelination.
• Vital signs stable; no signs of acute infection.
• Cerebrospinal fluid analysis may show JC virus presence.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Progressive multifocal leukoencephalopathy (ICD-10 Code A81.2)

Assessment:

• Diagnosis of Progressive multifocal leukoencephalopathy (ICD-10 A81.2) confirmed.
• Severity classified as advanced due to rapid progression.
• Contributing factors include underlying HIV/AIDS and recent immunosuppressive therapy.

Plan:

• Consult neurology for further management and potential clinical trials.
• Implement supportive care measures, including physical and occupational therapy.
• Monitor neurological status closely and adjust care plan as needed.
• Schedule follow-up appointments to assess progression and response to therapy.

Treatment & Plan Section for ICD-10 Code A81.2 – Progressive multifocal leukoencephalopathy

• Consider antiviral therapy if indicated, though no specific treatment exists for PML.
• Implement rehabilitation strategies to address functional impairments.
• Regular monitoring of neurological status and imaging as needed.
• Educate patient and family about the disease course and supportive resources.

Using ICD-10 Code A81.2 for Progressive multifocal leukoencephalopathy in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings in Subjective (S) and Objective (O) sections.
• Utilize A81.2 in billing to reflect the complexity of care provided.
• Align treatment plans with clinical guidelines to support justified billing.
• Include relevant CPT codes that correspond to services rendered for PML management.

Related ICD-10 Codes Often Used with Progressive multifocal leukoencephalopathy

• B97.7 – Viral infection due to JC virus
• C80.9 – Malignant neoplasm, unspecified

ICD-10 Code A81.2 in Medical Billing and Insurance for Progressive multifocal leukoencephalopathy

ICD-10 Code A81.2 is critical in medical billing, particularly in hospital, emergency room, or infectious disease care settings.

Billing Notes:

• Document all relevant clinical findings and patient history to support the use of A81.2.
• Use this code in conjunction with other relevant codes to capture the full clinical picture.
• Ensure compliance with payer guidelines for documentation and coding.
• Review coding updates regularly to maintain accuracy in billing practices.

Common CPT Pairings: